Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial)

S J Boccuzzi; W S Weintraub; A S Kosinski; J B Roehm; J L Klein

doi:10.1016/s0002-9149(97)00980-6

Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial)

Am J Cardiol. 1998 Mar 1;81(5):632-6. doi: 10.1016/s0002-9149(97)00980-6.

Authors

S J Boccuzzi¹, W S Weintraub, A S Kosinski, J B Roehm, J L Klein

Affiliation

¹ Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

PMID: 9514463
DOI: 10.1016/s0002-9149(97)00980-6

Abstract

A substudy of the Lovastatin Restenosis Trial in patients with elevated cholesterol (>200 mg/dl) showed no evidence of an effect of aggressive lipid lowering on restenosis, confirming the results of the main trial.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Angioplasty, Balloon, Coronary
Cholesterol, HDL / blood*
Cholesterol, LDL / blood*
Coronary Disease / blood*
Coronary Disease / prevention & control*
Coronary Disease / therapy
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Lovastatin / therapeutic use*
Male
Middle Aged
Randomized Controlled Trials as Topic
Recurrence
Treatment Outcome

Substances

Cholesterol, HDL
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lovastatin